Erik Kakes | International Sales & Marketing Director, Applikon Biotechnology

Erik Kakes 
graduated in 1984 from van’t Hoff Institute in Rotterdam with specialization in Biochemistry.  From 1984 until 1988 he worked for a sugar producing company, Cosun, optimizing Xanthan gum production. In 1988 he joined Applikon Biotechnology as a project manager. Via the R&D department he moved into Sales to become International Sales & Marketing Director. In 2008 he acquired the ownership of Applikon Biotechnology with Arthur Oudshoorn and Jaap Oostra through a management buyout. In 2020 the Swedish Getinge group acquired the shares of  Applikon Biotechnology.



About Applikon Biotechnology

Applikon Biotechnology is a world leader in developing and supplying advanced bioreactor systems for the production of vaccines, antibodies, tissues, bio-pharmaceuticals, nutraceuticals and biosimilars in the Pharmaceutical industry, as well as enzymes, food, feed, bio-fuel, bio-chemicals and bio-plastics for Industrial Biotechnology. Applikon can guide a customer through the whole upstream process, from initial screening up to full-scale production, using the same platform.

Sponsors & Partners

Powered by

Co-sponsor
Partner

Powered by:
Hyphen Projects   

    Connect with us                  

Access Biotech China Newsletter

Contact Us
Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
         
 
 
                                    

Subscribe
© Copyright 2021 by Hyphen Projects